Background. Recent studies have reported that asymptomatic left ventricular dysfunction (ALVD) in humans is characterized by early neurohumoral activation. Specifically, atrial natriuretic factor (ANF) and norepinephrine are activated without activation of the renin-angiotensin-aldosterone system (RAAS). The current study describes hemodynamic and renal function associated with this neurohumoral profile in a canine model of early and presumably "asymptomatic" ventricular dysfunction. We hypothesized that the neurohumoral profile observed in ALVD is associated with preservation of renal function despite significant hemodynamic compromise.
Background. Recent studies have reported that asymptomatic left ventricular dysfunction (ALVD) in humans is characterized by early neurohumoral activation. Specifically, atrial natriuretic factor (ANF) and norepinephrine are activated without activation of the renin-angiotensin-aldosterone system (RAAS). The current study describes hemodynamic and renal function associated with this neurohumoral profile in a canine model of early and presumably "asymptomatic" ventricular dysfunction. We hypothesized that the neurohumoral profile observed in ALVD is associated with preservation of renal function despite significant hemodynamic compromise.
Methods and Results. ALVD was produced by ventricular pacing at 180 beats per minute for 10 days. Intravascular volume expansion was performed before and after producing ALVD in eight conscious dogs. The model of ALVD was characterized by decreases in ejection fraction (48+2 to 29±4%), cardiac output (4.64±0.29 to 2.89±0.17 L/min), and mean arterial pressure (119±4 to 108±4 mm Hg). Atrial pressures and systemic vascular resistance were increased. ANF (60±19 to 165±27 pg/mL) and norepinephrine (382±+127 to 690±211 pg/mL) were activated, whereas the RAAS was not. Creatinine clearance and sodium excretion (UNa V) were unchanged after producing ALVD. The natriuretic response to volume expansion in ALVD was completely intact, with increases in UNa V similar to that observed with volume expansion before producing ALVD.
Conclusions. The current study demonstrates that significant ventricular dysfunction with peripheral vasoconstriction can be associated with normal renal function and thus suggests an important functional role for the neurohumoral profile of ALVD in preserving sodium balance. (Circulation 1993; 87:2016 -2022 The acute experiment was performed 5-7 days after pacemaker implantation. The night before the acute experiments, the animals were fasted and given 300 mg of lithium carbonate. The dogs were allowed access to water ad lib. The day of the acute experiment, the animals were briefly anesthetized with thiopental sodium (15 mg/kg) to allow percutaneous placement of a flow-directed balloon tip pulmonary artery catheter (model 93131-7F; American Edwards Laboratories, AHS del Caribe, Anasco, P.R.) via an external jugular vein for measurement of cardiac output and atrial pressures. A second balloon-tip catheter was inserted in the urinary bladder to allow urine collection. The animals were placed in a minimally restraining sling and allowed to regain consciousness and equilibrate for 90-120 minutes. The femoral artery catheter was connected to a pressure monitor during this period for on-line measurement of aortic pressure.
At the conclusion of the equilibration period, two 30-minute baseline urinary clearances were performed. Midway through each urinary clearance period, cardiac hemodynamics were measured and arterial blood was drawn for hormonal and electrolyte analysis. After the two 30-minute baseline urinary clearances, the animals were volume expanded with normal saline. Normal saline was infused at 2 mL-kg`. min-l. This was equivalent to approximately 5% body weight volume expansion over 30 minutes. A 15-minute urinary clearance was performed during the second half of volume expansion. The pulmonary artery and urinary catheters were then removed, the subcutaneous arterial catheter was flushed, and the dogs were returned to the kennels. The next morning, the pacemaker was programmed at 180 beats per minute. On the 10th day of pacing, after an overnight fast and after receiving lithium carbonate (300 mg), the acute volume expansion was performed in the exact same manner as it was before the induction of ALVD. At the end of the acute experiment, the catheter was flushed, and the dog was returned to the kennel.
A two-dimensional echocardiogram was performed at baseline and after the induction of ALVD on the 11th day of pacing. Echocardiograms were performed in the conscious state with the dog unrestrained and standing quietly. Each and was significantly increased after 10 days of pacing (382±127 to 690±211 pg/mLp=0.046).
As depicted in Figure 3 , basal renal hemodynamic and excretory function were not different from normal. Specifically, there was no change in creatinine clearance, urinary sodium excretion, fractional excretion of sodium, FELi, or urinary cGMP excretion.
Ejection fraction was measured by two-dimensional echocardiography in five dogs and decreased from 48±2% in the normal phase to 29±4% after 10 days of pacing. No dog developed ascites, edema, decrease in appetite, muscle wasting, or lassitude. Table 1 presents the hemodynamic, hormonal, and renal parameters before and during intravascular saline volume expansion in the normal and ALVD phases of the protocol. In both the normal phase and the ALVD phase, volume expansion resulted in increases in cardiac output and mean arterial pressure and was associated with an increase in atrial pressure and a decrease in SVR. The peak CO and MAP achieved in the ALVD phase were significantly lower than that obtained in the normal phase. The peak wedge pressure was also higher in the ALVD phase.
Hematocrit decreased from 39.0±1.5 at baseline to 26.4±12 with volume expansion. The percent change in plasma volume was 69±8%. When corrected for the change in plasma volume, plasma ANF and its second messenger cGMP both increased with volume expansion in the normal phase. Plasma ANF also increased with volume expansion in the ALVD phase, and this was associated with a strong trend toward an increase in The effect of volume expansion on creatinine clearance and renal excretory function during the normal and ALVD phases of the experiment are depicted in Table 1 . There was a trend toward an increase in creatinine clearance with volume expansion in each group, but this was not significant. There were similar increases in urinary volume, urinary sodium excretion, and fractional excretion of sodium with volume expansion in the normal and ALVD phase of the experiment. Whole kidney proximal tubule reabsorption of sodium as measured by FELi decreased to similar levels with volume expansion in the normal and ALVD phases of the experiment.
Discussion
Recent investigations have reported early neurohumoral activation in humans with ALVD. Specifically, ALVD was characterized by elevations in ANF and norepinephrine without activation of the circulating RAAS.' The current study in a canine model of ventricular dysfunction that mimics the humoral profile observed in ALVD provides insight into the biological significance of such endocrine activation in the control of cardiorenal function in early heart failure. In the current model of ALVD, decreased ventricular function was associated with increases in plasma norepinephrine. Despite significant ventricular dysfunction and peripheral vasoconstriction, sodium excretion was maintained at normal levels and the natriuresis associated with Hostetter et a129 in rats with mild ventricular dysfunction produced by experimental myocardial infarction that displayed an attenuated natriuretic response to acute volume expansion. In this previous report, the activity of the RAAS was not assessed. More recently, Volpe et a114 reported a blunted natriuretic response to volume expansion in a group of patients with dilated cardiomyopathy and mild CHF. These patients displayed a hetereogenous pattern of RAAS activation and an inability to increase stroke volume with volume expansion. These responses were also associated with an inability to increase plasma ANF.
In the current study, the ability to maintain a natriuretic response to volume expansion was associated with an increase in CO and MAP and decreases in SVR and plasma renin activity. While CO and MAP did not reach levels achieved in the normal phase, there were physiologically significant increases in CO and MAP with a marked decrease in SVR. This is in contrast to previous findings in severe CHF characterized by an absent natriuretic response to volume expansion associated with an inability to improve cardiac hemodynamics and with persistent activation of the RAAS.4 Thus, a critical degree of cardiac reserve and a complete lack of activation of the RAAS may play important roles in preserving sodium balance in early heart failure. Although the study of Hostetter et al demonstrated sodium retention despite increases in CO with volume expansion, Hollander and Judson30 studied patients with heart failure and found that patients who maintained their ability to respond to a sodium load increased their CO with exercise to a greater degree than those who retained sodium, which is consistent with the current observations. Proximal tubule sodium reabsorption was normal in the presence of ALVD and decreased with volume expansion, as was observed with volume expansion in the normal phase. Previous studies have demonstrated an inability to decrease proximal tubule sodium reabsorption and suppress plasma renin activity with volume expansion in severe CHF. 4 Cody et a13' postulated that the inability to suppress plasma renin activity in response to chronic oral sodium loading in a series of patients with CHF may be linked to a failure to enhance distal delivery of sodium to the macula densa. The current study would support such a hypothesis. Specifically, volume expansion in ALVD resulted in an increased delivery of sodium from the proximal tubule as determined by the increase in FELi. Such a response was associated with a decrease in plasma renin activity. As angiotensin II is known to stimulate and ANF to decrease sodium reabsorption by the proximal tubule, the neurohumoral milieu present in ALVD may preserve proximal tubule function in ALVD.
Previous studies from this laboratory and others have reported an inability to increase ANF levels with volume expansion in experimental chronic severe CHF.532 The current study demonstrates that in this model of early left ventricular dysfunction that mimics the neurohumoral activation reported in humans with ALVD, circulating ANF increased in response to volume expansion when corrected for changes in plasma volume with volume expansion. Thus, an increased amount of ANF must be released into the plasma as reflected by the increase in plasma level of ANF corrected for the increase in plasma volume. This increased ANF was associated with a strong trend toward an increase in the plasma cGMP levels. This increase in ANF occurred in response to appropriate and equivalent increases in cardiac filling pressures, which in part differs from the findings of Volpe et a114 in mild CHF where there was an attenuated increase in estimated left ventricular end-diastolic pressure associated with a blunted increase in plasma ANF. Thus, in this model of ALVD, a fundamental characteristic is an intact ANF response to increases in cardiac filling pressure produced by intravascular volume expansion. It is tempting to speculate that this intact response is responsible for the preserved renal natriuretic response and maintenance of body fluid hemostasis. Indeed, the elegant studies by Volpe et a114 would support such a speculation because an attenuated renal response to volume expansion was observed in patients with mild CHF and was associated with an attenuated increase in plasma ANF. Although the elevation in plasma ANF is a marker for ventricular dysfunction, previous studies by Lee et aP33 strongly support a role for ANF in maintaining renal function and preventing activation of the RAAS in acute CHF. Anti-ANF antibody studies by Drexler et a134 in rats with chronic CHF strongly support a role for ANF in preserving renal function and favorably affecting SVR. The current study extends these previous studies by demonstrating activation of ANF, suppression of the RAAS, and preservation of sodium excretion in the face of significant reduction in ventricular function and systemic hemodynamics. The current study provides insights into this preservation of renal function by demonstrating preservation of the proximal tubule response to acute volume expansion as discussed above.
Summary
The significance of the current study is that an experimental model of ALVD or very early heart failure has been developed and characterized in which ventricular dysfunction and peripheral vasoconstriction are observed but sodium homeostasis is preserved in the presence and absence of intravascular volume expansion. The neurohumoral profile that this model mimics is that of patients with ALVD. Because patients with ALVD remain asymptomatic in the absence of diuretics, an ability to maintain sodium balance is strongly implied. The current model demonstrates that significant ventricular dysfunction can be associated with an intact ability to maintain sodium balance. Thus, the neurohumoral profile observed in this model and in patients with ALVD may be importantly related to these physiological characteristics. Specifically, increased norepinephrine may be an indicator of activation of the sympathetic nervous system that contributes to the peripheral vasoconstriction, and increased ANF may be a marker for cardiac volume overload that contributes to the maintenance of sodium excretion and inhibition of the RAAS. As evidenced by recent studies, therapeutic strategies that maintain such neurohumoral adjustments may prolong the asymptomatic phase of ventricular dysfunction.
